Article Contents
REVIEW   Open Access     Cite

Wnt signaling arranges the fate of lipid metabolism: The role of gut microbes

More Information
  • DownLoad: Full size image
    1. Wnt signaling has dual roles in fat-cell development and metabolism.

      Metabolites from gut microbes can shift this balance, linking microbes to fat metabolism and tissue health.

      Gut microbes, their metabolites, and Wnt signaling offer potential therapeutic targets.

  • Disrupted lipid metabolism contributes to metabolic diseases and cancer. Gut microbes and their metabolites influence lipid absorption, synthesis, storage, and oxidation, while the Wnt signaling pathway is not only associated with lipid metabolism as a downstream metabolic pathway, but also serves as a regulatory system linking adipocyte lineage determination, tissue remodeling, and specific metabolic functions in mature adipocytes. How these components interact to form a gut microbes–metabolites–Wnt signaling axis, however, remains incompletely understood. Thus, this review focuses on the structure and physiological functions of Wnt, the association between Wnt signaling and host lipid metabolism. This review then examines how bile acids, amino acid metabolites, and short-chain fatty acids intersect with Wnt-related pathways across intestinal, hepatic, adipose, and cancer models. It further discusses the targeting of the gut microbes–metabolites–Wnt signaling axis for treatment, and explored the application prospects and challenges of gut microbes and their metabolites in the prevention and treatment of metabolic diseases and cancer.
  • 加载中
  • [1] Zarghamravanbakhsh P., Frenkel M. and Poretsky L. (2021). Metabolic causes and consequences of nonalcoholic fatty liver disease (NAFLD). Metab. Open. 12:100149. DOI:10.1016/j.metop.2021.100149

    View in Article CrossRef Google Scholar

    [2] Ma Y.F., Liu J.X. and Wang H.F. (2023). Porcine gut microbiota and lipid metabolism: Recent advances and future directions. Sci. Sin. Vitae. 53:616−625. DOI:10.1360/SSV-2021-0363

    View in Article CrossRef Google Scholar

    [3] Ross S.E., Hemati N., Longo K.A. et al. (2000). Inhibition of adipogenesis by Wnt signaling. Science 289:950−953. DOI:10.1126/science.289.5481.950

    View in Article CrossRef Google Scholar

    [4] Yang Loureiro Z., Joyce S., DeSouza T. et al. (2023). Wnt signaling preserves progenitor cell multipotency during adipose tissue development. Nat. Metab. 5:1014−1028. DOI:10.1038/s42255-023-00813-y

    View in Article CrossRef Google Scholar

    [5] Bennett C.N., Ross S.E., Longo K.A. et al. (2002). Regulation of Wnt signaling during adipogenesis. J. Biol. Chem. 277:30998−31004. DOI:10.1074/jbc.M204527200

    View in Article CrossRef Google Scholar

    [6] Liu H., Li P., Zhang S. et al. (2022a). Prrx1 marks stem cells for bone, white adipose tissue and dermis in adult mice. Nat. Genet. 54:1946−1958. DOI:10.1038/s41588-022-01227-4

    View in Article CrossRef Google Scholar

    [7] Zeve D., Seo J., Suh J.M. et al. (2012). Wnt signaling activation in adipose progenitors promotes insulin-independent muscle glucose uptake. Cell Metab. 15:492−504. DOI:10.1016/j.cmet.2012.03.010

    View in Article CrossRef Google Scholar

    [8] Bagchi D.P. and MacDougald O.A. (2021). Wnt signaling: From mesenchymal cell fate to lipogenesis and other mature adipocyte functions. Diabetes 70:1419−1430. DOI:10.2337/dbi20-0015

    View in Article CrossRef Google Scholar

    [9] Liu S. (2025). Mechanisms of gut microbiota in host fat deposition: Metabolites, signaling pathways, and translational applications. Front. Microbiol. 16:1675155. DOI:10.3389/fmicb.2025.1675155

    View in Article CrossRef Google Scholar

    [10] Hemba-Waduge R.U.S., Liu M. and Ji J.Y. (2025). Transcriptional regulation of lipid metabolism by Wnt signaling and hox protein cues. Deng W.M. and González C. (eds). The Drosophila Model in Cancer 61:81. DOI:10.1007/978-3-031-97035-1_4

    View in Article CrossRef Google Scholar

    [11] Sanam M., Hossain C.F.T.Z., Hyder T.B. et al. (2025). Bridging two worlds: Host microbiota crosstalk in health and dysregulation. Innate Immun. 31:17534259251392993. DOI:10.1177/17534259251392993.

    View in Article Google Scholar

    [12] Willert K. and Nusse R. (2012). Wnt proteins. Cold Spring Harb. Perspect. Biol. 4:a007864−a007864. DOI:10.1101/cshperspect.a007864

    View in Article CrossRef Google Scholar

    [13] Yu J. and Virshup D.M. (2022). Functional regulation of Wnt protein through post-translational modifications. Biochem. Soc. Trans. 50:1797−1808. DOI:10.1042/BST20220735

    View in Article CrossRef Google Scholar

    [14] Janda C.Y., Waghray D., Levin A.M. et al. (2012). Structural basis of Wnt recognition by frizzled. Science 337:59−64. DOI:10.1126/science.1222879

    View in Article CrossRef Google Scholar

    [15] MacDonald B.T., Hien A., Zhang X. et al. (2014). Disulfide bond requirements for active Wnt ligands. J. Biol. Chem. 289:18122−18136. DOI:10.1074/jbc.M114.575027

    View in Article CrossRef Google Scholar

    [16] Liu Y., Qi X., Donnelly L. et al. (2022b). Mechanisms and inhibition of porcupine-mediated Wnt acylation. Nature 607:816−822. DOI:10.1038/s41586-022-04952-2

    View in Article CrossRef Google Scholar

    [17] Kurayoshi M., Yamamoto H., Izumi S. et al. (2007). Post-translational palmitoylation and glycosylation of Wnt-5a are necessary for its signalling. Biochem. J. 402:515−523. DOI:10.1042/BJ20061476

    View in Article CrossRef Google Scholar

    [18] Nygaard R., Yu J., Kim J. et al. (2021). Structural basis of WLS/Evi-mediated Wnt transport and secretion. Cell 184:194−206.e14. DOI:10.1016/j.cell.2020.11.038

    View in Article CrossRef Google Scholar

    [19] Zhong Q., Zhao Y., Ye F. et al. (2021). Cryo-EM structure of human Wntless in complex with Wnt3a. Nat. Commun. 12:4541. DOI:10.1038/s41467-021-24731-3

    View in Article CrossRef Google Scholar

    [20] Mikels A.J. and Nusse R. (2006). Purified Wnt5a protein activates or inhibits β-catenin–TCF signaling depending on receptor context. PLoS Biol. 4:e115. DOI:10.1371/journal.pbio.0040115

    View in Article CrossRef Google Scholar

    [21] Nusse R. and Clevers H. (2017). Wnt/β-catenin signaling, disease, and emerging therapeutic modalities. Cell 169:985−999. DOI:10.1016/j.cell.2017.05.016

    View in Article CrossRef Google Scholar

    [22] Qi X., Hu Q., Elghobashi-Meinhardt N. et al. (2023). Molecular basis of Wnt biogenesis, secretion, and Wnt7-specific signaling. Cell 186:5028−5040.e14. DOI:10.1016/j.cell.2023.09.021

    View in Article CrossRef Google Scholar

    [23] Miranda M., Galli L.M., Enriquez M. et al. (2014). Identification of the WNT1 residues required for palmitoylation by porcupine. FEBS Lett. 588:4815−4824. DOI:10.1016/j.febslet.2014.11.016

    View in Article CrossRef Google Scholar

    [24] Thomas K.R. and Capecchi M.R. (1990). Targeted disruption of the murine int-1 proto-oncogene resulting in severe abnormalities in midbrain and cerebellar development. Nature 346:847−850. DOI:10.1038/346847a0

    View in Article CrossRef Google Scholar

    [25] Laine C.M., Joeng K.S., Campeau P.M. et al. (2013). WNT1 mutations in early-onset osteoporosis and osteogenesis imperfecta. N. Engl. J. Med. 368:1809−1816. DOI:10.1056/NEJMoa1215458

    View in Article CrossRef Google Scholar

    [26] Mihara E., Hirai H., Yamamoto H. et al. (2016). Active and water-soluble form of lipidated Wnt protein is maintained by a serum glycoprotein afamin/α-albumin. eLife. 5:e11621. DOI:10.7554/eLife.11621

    View in Article CrossRef Google Scholar

    [27] Gao X. and Hannoush R.N. (2014). Single-cell imaging of Wnt palmitoylation by the acyltransferase porcupine. Nat. Chem. Biol. 10:61−68. DOI:10.1038/nchembio.1392

    View in Article CrossRef Google Scholar

    [28] Rios-Esteves J., Haugen B. and Resh M.D. (2014). Identification of key residues and regions important for porcupine-mediated Wnt acylation. J. Biol. Chem. 289:17009−17019. DOI:10.1074/jbc.M114.561209

    View in Article CrossRef Google Scholar

    [29] Takada S., Stark K.L., Shea M.J. et al. (1994). Wnt-3a regulates somite and tailbud formation in the mouse embryo. Genes Dev. 8:174−189. DOI:10.1101/gad.8.2.174

    View in Article CrossRef Google Scholar

    [30] Willert K., Brown J.D., Danenberg E. et al. (2003). Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 423:448−452. DOI:10.1038/nature01611

    View in Article CrossRef Google Scholar

    [31] de Winter T.J.J. and Nusse R. (2021). Running against the Wnt: How Wnt/β-catenin suppresses adipogenesis. Front. Cell Dev. Biol. 9:627429. DOI:10.3389/fcell.2021.627429

    View in Article CrossRef Google Scholar

    [32] Bauer M., Bénard J., Gaasterland T. et al. (2013). WNT5A encodes two isoforms with distinct functions in cancers. PLoS One. 8:e80526. DOI:10.1371/journal.pone.0080526

    View in Article CrossRef Google Scholar

    [33] Kamizaki K., Minami Y. and Nishita M. (2024). Role of the ror family receptors in Wnt5a signaling. In Vitro Cell. Dev. Biol. Anim. 60:489−501. DOI:10.1007/s11626-024-00885-4

    View in Article CrossRef Google Scholar

    [34] Hei Y., Hu Q., Manisa B. et al. (2024). Synthesis and frizzled-receptor binding of a WNT5A hairpin-3 peptide. Chem. Commun. 60:13534−13537. DOI:10.1039/D4CC04393F

    View in Article CrossRef Google Scholar

    [35] Ge Y., de Almeida Magalhaes T., Wu H. et al. (2026). Conformational cycling of the Wntless transporter drives trafficking and secretion of Wnt morphogens. Nat. Commun. DOI:10.1038/s41467-026-74521-y.

    View in Article Google Scholar

    [36] Oishi I., Suzuki H., Onishi N. et al. (2003). The receptor tyrosine kinase Ror2 is involved in non-canonical Wnt5a/JNK signalling pathway. Genes Cells. 8:645−654. DOI:10.1046/j.1365-2443.2003.00662.x

    View in Article CrossRef Google Scholar

    [37] McQuate A., Latorre-Esteves E. and Barria A. (2017). A Wnt/Calcium signaling cascade regulates Neuronal Excitability and Trafficking of NMDARs. Cell Rep. 21:60−69. DOI:10.1016/j.celrep.2017.09.023

    View in Article CrossRef Google Scholar

    [38] Yamaguchi T.P., Bradley A., McMahon A.P. et al. (1999). A Wnt5a pathway underlies outgrowth of multiple structures in the vertebrate embryo. Development 126:1211−1223. DOI:10.1242/dev.126.6.1211

    View in Article CrossRef Google Scholar

    [39] Ouchi N., Higuchi A., Ohashi K. et al. (2010). Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity. Science 329:454−457. DOI:10.1126/science.1188280

    View in Article CrossRef Google Scholar

    [40] Fuster J.J., Zuriaga M.A., Ngo D.T.M. et al. (2015). Noncanonical Wnt signaling promotes obesity-induced adipose tissue inflammation and metabolic dysfunction independent of adipose tissue expansion. Diabetes 64:1235−1248. DOI:10.2337/db14-1164

    View in Article CrossRef Google Scholar

    [41] Zuriaga M.A., Fuster J.J., Farb M.G. et al. (2017). Activation of non-canonical WNT signaling in human visceral adipose tissue contributes to local and systemic inflammation. Sci. Rep. 7:17326. DOI:10.1038/s41598-017-17509-5

    View in Article CrossRef Google Scholar

    [42] Reggio A., Rosina M., Palma A. et al. (2020). Adipogenesis of skeletal muscle fibro/adipogenic progenitors is affected by the WNT5a/GSK3/β-catenin axis. Cell Death Differ. 27:2921−2941. DOI:10.1038/s41418-020-0551-y

    View in Article CrossRef Google Scholar

    [43] Kirikoshi H., Sekihara H. and Katoh M. (2001a). Molecular cloning and characterization of human WNT7B. Int. J. Oncol. 19:779−783. DOI:10.3892/ijo.19.4.779

    View in Article CrossRef Google Scholar

    [44] Schmidt M., Poser C., Janster C. et al. (2022). The hairpin region of WNT7A is sufficient for binding to the Frizzled7 receptor and to elicit signaling in myogenic cells. Comput. Struct. Biotechnol. J. 20:6348−6359. DOI:10.1016/j.csbj.2022.10.047

    View in Article CrossRef Google Scholar

    [45] Cho C., Smallwood P.M. and Nathans J. (2017). Reck and Gpr124 are essential receptor cofactors for Wnt7a/Wnt7b-specific signaling in mammalian CNS angiogenesis and blood-brain barrier regulation. Neuron 95:1056−1073.e5. DOI:10.1016/j.neuron.2017.07.031

    View in Article CrossRef Google Scholar

    [46] Eubelen M., Bostaille N., Cabochette P. et al. (2018). A molecular mechanism for Wnt ligand-specific signaling. Science 361:eaat1178. DOI:10.1126/science.aat1178

    View in Article CrossRef Google Scholar

    [47] Le Grand F., Jones A.E., Seale V. et al. (2009). Wnt7a activates the planar cell polarity pathway to drive the symmetric expansion of satellite stem cells. Cell Stem Cell. 4:535−547. DOI:10.1016/j.stem.2009.03.013

    View in Article CrossRef Google Scholar

    [48] Parr B.A. and McMahon A.P. (1995). Dorsalizing signal Wnt-7a required for normal polarity of D–V and A–P axes of mouse limb. Nature 374:350−353. DOI:10.1038/374350a0

    View in Article CrossRef Google Scholar

    [49] Stenman J.M., Rajagopal J., Carroll T.J. et al. (2008). Canonical Wnt signaling regulates organ-specific assembly and differentiation of CNS vasculature. Science 322:1247−1250. DOI:10.1126/science.1164594

    View in Article CrossRef Google Scholar

    [50] Daneman R., Agalliu D., Zhou L. et al. (2009). Wnt/β-catenin signaling is required for CNS, but not non-CNS, angiogenesis. Proc. Natl. Acad. Sci. U.S.A. 106:641−646. DOI:10.1073/pnas.0805165106

    View in Article CrossRef Google Scholar

    [51] Shu W., Jiang Y.Q., Lu M.M. et al. (2002). Wnt7b regulates mesenchymal proliferation and vascular development in the lung. Development 129:4831−4842. DOI:10.1242/dev.129.20.4831

    View in Article CrossRef Google Scholar

    [52] Kirikoshi H., Sekihara H. and Katoh M. (2001b). WNT10A and WNT6, clustered in human chromosome 2q35 Region with head-to-tail manner, are strongly coexpressed in SW480 cells. Biochem. Biophys. Res. Commun. 283:798−805. DOI:10.1006/bbrc.2001.4855

    View in Article CrossRef Google Scholar

    [53] Benard E.L. and Hammerschmidt M. (2025). The fundamentals of WNT10A. Differentiation 142:100838. DOI:10.1016/j.diff.2025.100838

    View in Article CrossRef Google Scholar

    [54] Ain Q.U., Seemab U., Rashid S. et al. (2013). Prediction of structure of human WNT-CRD (FZD) complex for computational drug repurposing. PLoS One. 8:e54630. DOI:10.1371/journal.pone.0054630

    View in Article CrossRef Google Scholar

    [55] Hirai H., Matoba K., Mihara E. et al. (2019). Crystal structure of a mammalian Wnt–frizzled complex. Nat. Struct. Mol. Biol. 26:372−379. DOI:10.1038/s41594-019-0216-z

    View in Article CrossRef Google Scholar

    [56] Cawthorn W.P., Bree A.J., Yao Y. et al. (2012). Wnt6, Wnt10a and Wnt10b inhibit adipogenesis and stimulate osteoblastogenesis through a β-catenin-dependent mechanism. Bone 50:477−489. DOI:10.1016/j.bone.2011.08.010

    View in Article CrossRef Google Scholar

    [57] Kang S., Bennett C. N., Gerin I. et al. (2007). Wnt signaling stimulates osteoblastogenesis of mesenchymal precursors by suppressing C/EBPα and PPARγ. J. Biol. Chem. 282:14515−14524. DOI:10.1074/jbc.M700030200

    View in Article CrossRef Google Scholar

    [58] Fang Q., Ye L., Han L. et al. (2025). LGR4 is a key regulator of hepatic gluconeogenesis. Free Radic. Biol. Med. 229:183−194. DOI:10.1016/j.freeradbiomed.2025.01.025

    View in Article CrossRef Google Scholar

    [59] Uno K., Uchino T., Suzuki T. et al. (2025). Rspo3-mediated metabolic liver zonation regulates systemic glucose metabolism and body mass in mice. PLoS Biol. 23:e3002955. DOI:10.1371/journal.pbio.3002955

    View in Article CrossRef Google Scholar

    [60] Ayala I., Hebbale S.K., Mononen J. et al. (2025). The spatial transcriptional activity of hepatic TCF7L2 regulates zonated metabolic pathways that contribute to liver fibrosis. Nat. Commun. 16:3408. DOI:10.1038/s41467-025-58714-5

    View in Article CrossRef Google Scholar

    [61] Silvano S., Napolitano T., Plaisant M. et al. (2025). RSPO1, a potent inducer of pancreatic β cell neogenesis. Cell Rep. Med. 6:102126. DOI:10.1016/j.xcrm.2025.102126

    View in Article CrossRef Google Scholar

    [62] Zhou A.X., Mondal T., Tabish A.M. et al. (2021). The long noncoding RNA TUNAR modulates Wnt signaling and regulates human β-cell proliferation. Am. J. Physiol. Endocrinol. Metab. 320:E846−E857. DOI:10.1152/ajpendo.00335.2020

    View in Article CrossRef Google Scholar

    [63] Kang S.W.S., Cunningham R.P., Miller C.B. et al. (2024). A spatial map of hepatic mitochondria uncovers functional heterogeneity shaped by nutrient-sensing signaling. Nat. Commun. 15:1799. DOI:10.1038/s41467-024-45751-9

    View in Article CrossRef Google Scholar

    [64] Badakhshi Y., Shao W., Liu D. et al. (2021). Estrogen-Wnt signaling cascade regulates expression of hepatic fibroblast growth factor 21. Am. J. Physiol. Endocrinol. Metab. 321:E292−E304. DOI:10.1152/ajpendo.00638.2020

    View in Article CrossRef Google Scholar

    [65] Song P., Gao Z., Bao Y. et al. (2024). Wnt/β-catenin signaling pathway in carcinogenesis and cancer therapy. J. Hematol. Oncol. 17:46. DOI:10.1186/s13045-024-01563-4

    View in Article CrossRef Google Scholar

    [66] Balatskyi V.V., Sowka A., Dobrzyn P. et al. (2023). WNT/β-catenin pathway is a key regulator of cardiac function and energetic metabolism. Acta Physiol. 237:e13912. DOI:10.1111/apha.13912

    View in Article CrossRef Google Scholar

    [67] Xu G., Chen T., Zhang Q. et al. (2026). Wnt/β-catenin signaling restrains developmental beige adipocyte thermogenesis and its inhibition imprints long-term energy expenditure. bioRxiv. DOI:10.64898/2026.03.23.713637.

    View in Article Google Scholar

    [68] Liu M., Hemba-Waduge R.U.S., Li X. et al. (2024). Wnt/Wingless signaling promotes lipid mobilization through signal-induced transcriptional repression. Proc. Natl. Acad. Sci. U.S.A. 121:e2322066121. DOI:10.1073/pnas.2322066121

    View in Article CrossRef Google Scholar

    [69] Yu F., Yu C., Li F. et al. (2021). Wnt/β-catenin signaling in cancers and targeted therapies. Signal Transduct Target Ther. 6:307. DOI:10.1038/s41392-021-00701-5

    View in Article CrossRef Google Scholar

    [70] Valvezan A.J., Zhang F., Diehl J.A. et al. (2012). Adenomatous polyposis coli (APC) regulates multiple signaling pathways by enhancing glycogen synthase kinase-3 (GSK-3) activity. J. Biol. Chem. 287:3823−3832. DOI:10.1074/jbc.M111.323337

    View in Article CrossRef Google Scholar

    [71] Niehrs C. and Acebron S.P. (2012). Mitotic and mitogenic Wnt signalling. EMBO J. 31:2705−2713. DOI:10.1038/emboj.2012.124

    View in Article CrossRef Google Scholar

    [72] Jeong W. and Jho E.H. (2021). Regulation of the low-density lipoprotein receptor-related protein LRP6 and its association with disease: Wnt/β-catenin signaling and beyond. Front. Cell Dev. Biol. 9:714330. DOI:10.3389/fcell.2021.714330

    View in Article CrossRef Google Scholar

    [73] González-Sancho J.M., Brennan K.R., Castelo-Soccio L.A. et al. (2004). Wnt proteins induce dishevelled phosphorylation via an LRP5/6- independent mechanism, irrespective of their ability to stabilize β-Catenin. Mol. Cell. Biol. 24:4757−4768. DOI:10.1128/MCB.24.11.4757-4768.2004

    View in Article CrossRef Google Scholar

    [74] Niehrs C. and Shen J. (2010). Regulation of Lrp6 phosphorylation. Cell. Mol. Life Sci. 67:2551−2562. DOI:10.1007/s00018-010-0329-3

    View in Article CrossRef Google Scholar

    [75] Krieghoff E., Behrens J.R. and Mayr B. (2006). Nucleo-cytoplasmic distribution of β-catenin is regulated by retention. J. Cell Sci. 119:1453−1463. DOI:10.1242/jcs.02864

    View in Article CrossRef Google Scholar

    [76] Lu F.I., Sun Y.H., Wei C.Y. et al. (2014). Tissue-specific derepression of TCF/LEF controls the activity of the Wnt/β-catenin pathway. Nat. Commun. 5:5368. DOI:10.1038/ncomms6368

    View in Article CrossRef Google Scholar

    [77] Shang S., Hua F. and Hu Z.W. (2017). The regulation of β-catenin activity and function in cancer: Therapeutic opportunities. Oncotarget 8:33972−33989. DOI:10.18632/oncotarget.15687

    View in Article CrossRef Google Scholar

    [78] Saito-Diaz K., Benchabane H., Tiwari A. et al. (2018). APC inhibits ligand-independent Wnt signaling by the clathrin endocytic pathway. Dev. Cell. 44:566−581.e8. DOI:10.1016/j.devcel.2018.02.013

    View in Article CrossRef Google Scholar

    [79] Chen L.J., Lin X.X., Guo J. et al. (2021). Lrp6 genotype affects individual susceptibility to nonalcoholic fatty liver disease and silibinin therapeutic response via Wnt/β-catenin-Cyp2e1 signaling. Int. J. Biol. Sci. 17:3936−3953. DOI:10.7150/ijbs.63732

    View in Article CrossRef Google Scholar

    [80] Bagchi D.P., Nishii A., Li Z. et al. (2020a). Wnt/β-catenin signaling regulates adipose tissue lipogenesis and adipocyte-specific loss is rigorously defended by neighboring stromal-vascular cells. Mol. Metab. 42:101078. DOI:10.1016/j.molmet.2020.101078

    View in Article CrossRef Google Scholar

    [81] Lefterova M.I., Zhang Y., Steger D.J. et al. (2008). PPARγ and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale. Genes Dev. 22:2941−2952. DOI:10.1101/gad.1709008

    View in Article CrossRef Google Scholar

    [82] Mikkelsen T.S., Xu Z., Zhang X. et al. (2010). Comparative epigenomic analysis of murine and human adipogenesis. Cell 143:156−169. DOI:10.1016/j.cell.2010.09.006

    View in Article CrossRef Google Scholar

    [83] Bagchi D.P., Li Z., Corsa C.A. et al. (2020b). Wntless regulates lipogenic gene expression in adipocytes and protects against diet-induced metabolic dysfunction. Mol. Metab. 39:100992. DOI:10.1016/j.molmet.2020.100992

    View in Article CrossRef Google Scholar

    [84] Geoghegan G., Simcox J., Seldin M.M. et al. (2019). Targeted deletion of Tcf7l2 in adipocytes promotes adipocyte hypertrophy and impaired glucose metabolism. Mol. Metab. 24:44−63. DOI:10.1016/j.molmet.2019.03.003

    View in Article CrossRef Google Scholar

    [85] Akoumianakis I., Sanna F., Margaritis M. et al. (2019). Adipose tissue–derived WNT5A regulates vascular redox signaling in obesity via USP17/RAC1-mediated activation of NADPH oxidases. Sci. Transl. Med. 11:eaav5055. DOI:10.1126/scitranslmed.aav5055

    View in Article CrossRef Google Scholar

    [86] Bryja V., Andersson E.R., Schambony A. et al. (2009). The extracellular domain of Lrp5/6 inhibits noncanonical Wnt signaling in vivo. Mol. Biol. Cell. 20:924−936. DOI:10.1091/mbc.e08-07-0711

    View in Article CrossRef Google Scholar

    [87] van Amerongen R., Fuerer C., Mizutani M. et al. (2012). Wnt5a can both activate and repress Wnt/β-catenin signaling during mouse embryonic development. Dev. Biol. 369:101−114. DOI:10.1016/j.ydbio.2012.06.020

    View in Article CrossRef Google Scholar

    [88] Habas R., Kato Y. and He X. (2001). Wnt/Frizzled activation of rho regulates vertebrate gastrulation and requires a novel formin homology protein daam1. Cell. 107:843−854. DOI:10.1016/S0092-8674(01)00614-6

    View in Article CrossRef Google Scholar

    [89] Habas R., Dawid I.B. and He X. (2003). Coactivation of Rac and Rho by Wnt/Frizzled signaling is required for vertebrate gastrulation. Genes Dev. 17:295−309. DOI:10.1101/gad.1022203

    View in Article CrossRef Google Scholar

    [90] Bhatt P.M. and Malgor R. (2014). Wnt5a: A player in the pathogenesis of atherosclerosis and other inflammatory disorders. Atherosclerosis. 237:155−162. DOI:10.1016/j.atherosclerosis.2014.08.027

    View in Article CrossRef Google Scholar

    [91] Jing L., Wang H., Xia S. et al. (2025). Wnt/Ca2+ signaling: Dichotomous roles in regulating tumor progress (Review). Oncol. Lett. 30:1−12. DOI:10.3892/ol.2025.15145

    View in Article CrossRef Google Scholar

    [92] Slusarski D.C., Corces V.G. and Moon R.T. (1997). Interaction of Wnt and a Frizzled homologue triggers G-protein-linked phosphatidylinositol signalling. Nature 390:410−413. DOI:10.1038/37138

    View in Article CrossRef Google Scholar

    [93] Kohn A.D. and Moon R.T. (2005). Wnt and calcium signaling: β-catenin-independent pathways. Cell Calcium. 38:439−446. DOI:10.1016/j.ceca.2005.06.022

    View in Article CrossRef Google Scholar

    [94] Sheldahl L.C., Park M., Malbon C.C. et al. (1999). Protein kinase C is differentially stimulated by Wnt and Frizzled homologs in a G-protein-dependent manner. Curr. Biol. 9:695−S1. DOI:10.1016/S0960-9822(99)80310-8

    View in Article CrossRef Google Scholar

    [95] Kim Y.H. and Pyo S. (2019). Interleukin-10 suppresses adipogenesis via Wnt5a signaling pathway in 3T3-L1 preadipocytes. Biochem. Biophys. Res. Commun. 509:877−885. DOI:10.1016/j.bbrc.2019.01.033

    View in Article CrossRef Google Scholar

    [96] Bilkovski R., Schulte D.M., Oberhauser F. et al. (2010). Role of Wnt-5a in the determination of human mesenchymal stem cells into preadipocytes. J. Biol. Chem. 285:6170−6178. DOI:10.1074/jbc.M109.054338

    View in Article CrossRef Google Scholar

    [97] Kanazawa A., Tsukada S., Kamiyama M. et al. (2005). Wnt5b partially inhibits canonical Wnt/β-catenin signaling pathway and promotes adipogenesis in 3T3-L1 preadipocytes. Biochem. Biophys. Res. Commun. 330:505−510. DOI:10.1016/j.bbrc.2005.03.007

    View in Article CrossRef Google Scholar

    [98] van Tienen F.H.J., Laeremans H., van der Kallen C.J.H. et al. (2009). Wnt5b stimulates adipogenesis by activating PPARγ, and inhibiting the β-catenin dependent Wnt signaling pathway together with Wnt5a. Biochem. Biophys. Res. Commun. 387:207−211. DOI:10.1016/j.bbrc.2009.07.004

    View in Article CrossRef Google Scholar

    [99] Nishizuka M., Koyanagi A., Osada S. et al. (2008). Wnt4 and Wnt5a promote adipocyte differentiation. FEBS Lett. 582:3201−3205. DOI:10.1016/j.febslet.2008.08.011

    View in Article CrossRef Google Scholar

    [100] Menck K., Heinrichs S., Baden C. et al. (2021). The WNT/ROR pathway in cancer: From signaling to therapeutic intervention. Cell 10:142. DOI:10.3390/cells10010142

    View in Article CrossRef Google Scholar

    [101] Farb M.G., Karki S., Park S.Y. et al. (2016). WNT5A-JNK regulation of vascular insulin resistance in human obesity. Vasc. Med. 21:489−496. DOI:10.1177/1358863X16666693

    View in Article CrossRef Google Scholar

    [102] Tang Q., Chen C., Zhang Y. et al. (2018). Wnt5a regulates the cell proliferation and adipogenesis via MAPK-independent pathway in early stage of obesity. Cell Biol. Int. 42:63−74. DOI:10.1002/cbin.10862

    View in Article CrossRef Google Scholar

    [103] Zhu L., Shahein A., Choudhury S. et al. (2018). Upregulation of non-canonical Wnt ligands and oxidative glucose metabolism in NASH induced by methionine-choline-deficient diet. Trends Cell Mol. Biol. 13:47. DOI:10.31300/TCMB.13.2018.47-56

    View in Article CrossRef Google Scholar

    [104] Carbone C., Piro G., Gaianigo N. et al. (2018). Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling. Int. J. Obes. 42:334−343. DOI:10.1038/ijo.2017.285

    View in Article CrossRef Google Scholar

    [105] Cabrae R., Dubuquoy C., Caüzac M. et al. (2020). Insulin activates hepatic Wnt/β-catenin signaling through stearoyl-CoA desaturase 1 and porcupine. Sci. Rep. 10:5186. DOI:10.1038/s41598-020-61869-4

    View in Article CrossRef Google Scholar

    [106] Guo F., Seldin M., Péterfy M. et al. (2021). NOTUM promotes thermogenic capacity and protects against diet-induced obesity in male mice. Sci. Rep. 11:16409. DOI:10.1038/s41598-021-95720-1

    View in Article CrossRef Google Scholar

    [107] Jiang H., Tao X., Yu S. et al. (2026). Adipocytic sclerostin loop3-LRP4 interaction required by sclerostin to impair whole-body lipid and glucose metabolism. Nat. Commun. 17:1812. DOI:10.1038/s41467-026-68526-w

    View in Article CrossRef Google Scholar

    [108] Procházková N., Laursen M.F., La Barbera G. et al. (2024). Gut physiology and environment explain variations in human gut microbiome composition and metabolism. Nat. Microbiol. 9:3210−3225. DOI:10.1038/s41564-024-01856-x

    View in Article CrossRef Google Scholar

    [109] Lin X., He K., Gu Z. et al. (2024). Emerging chemophysiological diversity of gut microbiota metabolites. Trends Pharmacol. Sci. 45:824−838. DOI:10.1016/j.tips.2024.07.006

    View in Article CrossRef Google Scholar

    [110] Cheng B., Wang Y.X., Wang Y.T. et al. (2025). Primary-secondary-tertiary axis of bile acid metabolism in healthy subjects. J. Proteome Res. 24:5572−5584. DOI:10.1021/acs.jproteome.5c00343

    View in Article CrossRef Google Scholar

    [111] Zhang J., Lyu A. and Wang C. (2023a). The molecular insights of bile acid homeostasis in host diseases. Life Sci. 330:121919. DOI:10.1016/j.lfs.2023.121919

    View in Article CrossRef Google Scholar

    [112] Fleishman J.S. and Kumar S. (2024). Bile acid metabolism and signaling in health and disease: Molecular mechanisms and therapeutic targets. Signal Transduct. Target. Ther. 9:97. DOI:10.1038/s41392-024-01811-6

    View in Article CrossRef Google Scholar

    [113] Ridlon J.M., Kang D. J., Hylemon P. B. (2006). Bile salt biotransformations by human intestinal bacteria. J. Lipid Res. 47:241−259. DOI:10.1194/jlr.R500013-JLR200

    View in Article CrossRef Google Scholar

    [114] Sayin S.I., Wahlström A., Felin J. et al. (2013). Gut microbiota regulates bile acid metabolism by reducing the levels of Tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 17:225−235. DOI:10.1016/j.cmet.2013.01.003

    View in Article CrossRef Google Scholar

    [115] Jia E.T., Liu Z.Y., Pan M. et al. (2019). Regulation of bile acid metabolism-related signaling pathways by gut microbiota in diseases. J. Zhejiang Univ. Sci. B. 20:781−792. DOI:10.1631/jzus.B1900073

    View in Article CrossRef Google Scholar

    [116] Gougelet A., Torre C., Veber P. et al. (2014). T-cell factor 4 and β-catenin chromatin occupancies pattern zonal liver metabolism in mice. Hepatology 59:2344−2357. DOI:10.1002/hep.26924

    View in Article CrossRef Google Scholar

    [117] Behari J., Yeh T.H., Krauland L. et al. (2010). Liver-specific β-catenin knockout mice exhibit defective bile acid and cholesterol homeostasis and increased susceptibility to diet-induced steatohepatitis. Am. J. Pathol. 176:744−753. DOI:10.2353/ajpath.2010.090667

    View in Article CrossRef Google Scholar

    [118] Yan W., Zhang K., Guo J. et al. (2025). Bile acid-mediated gut-liver axis crosstalk: The role of nuclear receptor signaling in dynamic regulation of inflammatory networks. Front. Immunol. 16:1595486. DOI:10.3389/fimmu.2025.1595486

    View in Article CrossRef Google Scholar

    [119] Thompson M.D., Moghe A., Cornuet P. et al. (2018). β-catenin regulation of farnesoid X receptor signaling and bile acid metabolism during murine cholestasis. Hepatology 67:955−971. DOI:10.1002/hep.29371

    View in Article CrossRef Google Scholar

    [120] Li J.Y., Gillilland M., Lee A.A. et al. (2022). Secondary bile acids mediate high-fat diet–induced upregulation of R-spondin 3 and intestinal epithelial proliferation. JCI Insight. 7:e148309. DOI:10.1172/jci.insight.148309

    View in Article CrossRef Google Scholar

    [121] Dong X., Cai C. and Fu T. (2023). FXR suppresses colorectal cancer by inhibiting the Wnt/β-catenin pathway via activation of TLE3. Genes Diss. 10:719−722. DOI:10.1016/j.gendis.2022.09.006

    View in Article CrossRef Google Scholar

    [122] Liu M., Sun J., Jia Z. et al. (2026). Medicago Sativa L. Saponin-driven lactobacillus intestinalis restores intestinal stemness in naturally aged mice via the bile acid-FXR-Wnt signaling axis. Adv. Sci. 13:e15370. DOI:10.1002/advs.202515370

    View in Article CrossRef Google Scholar

    [123] Holt J. A., Luo G., Billin A. N. et al. (2003). Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. Genes Dev. 17:1581−1591. DOI:10.1101/gad.1083503

    View in Article CrossRef Google Scholar

    [124] Inagaki T., Choi M., Moschetta A. et al. (2005). Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab. 2:217−225. DOI:10.1016/j.cmet.2005.09.001

    View in Article CrossRef Google Scholar

    [125] Zhang J. H., Nolan J. D., Kennie S. L. et al. (2013). Potent stimulation of fibroblast growth factor 19 expression in the human ileum by bile acids. Am. J. Physiol. Gastrointest. Liver Physiol. 304:G940−G948. DOI:10.1152/ajpgi.00398.2012

    View in Article CrossRef Google Scholar

    [126] Li X., Lu W., Kharitonenkov A. et al. (2024). Targeting the FGF19–FGFR4 pathway for cholestatic, metabolic, and cancerous diseases. J. Intern. Med. 295:292−312. DOI:10.1111/joim.13767

    View in Article CrossRef Google Scholar

    [127] Bhat N., Esteghamat F., Chaube B.K. et al. (2022). TCF7L2 transcriptionally regulates Fgf15 to maintain bile acid and lipid homeostasis through gut-liver crosstalk. FASEB J. 36:e22185. DOI:10.1096/fj.202101607R

    View in Article CrossRef Google Scholar

    [128] Rinella M.E., Lieu H.D., Kowdley K.V. et al. (2024). A randomized, double-blind, placebo-controlled trial of aldafermin in patients with NASH and compensated cirrhosis. Hepatology 79:674−689. DOI:10.1097/HEP.0000000000000607

    View in Article CrossRef Google Scholar

    [129] Gao J., Xu K., Liu H. et al. (2018). Impact of the gut microbiota on intestinal immunity mediated by tryptophan metabolism. Front. Cell. Infect. Microbiol. 8:13. DOI:10.3389/fcimb.2018.00013

    View in Article CrossRef Google Scholar

    [130] Williams B.B., Van Benschoten A.H., Cimermancic P. et al. (2014). Discovery and characterization of gut microbiota decarboxylases that can produce the neurotransmitter tryptamine. Cell Host Microbe. 16:495−503. DOI:10.1016/j.chom.2014.09.001

    View in Article CrossRef Google Scholar

    [131] Dodd D., Spitzer M. H., Van Treuren W. et al. (2017). A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites. Nature 551:648−652. DOI:10.1038/nature24661

    View in Article CrossRef Google Scholar

    [132] Kurnasov O., Jablonski L., Polanuyer B. et al. (2003). Aerobic tryptophan degradation pathway in bacteria: Novel kynurenine formamidase. FEMS Microbiol. Lett. 227:219−227. DOI:10.1016/S0378-1097(03)00684-0

    View in Article CrossRef Google Scholar

    [133] Bortolotti P., Hennart B., Thieffry C. et al. (2016). Tryptophan catabolism in Pseudomonas aeruginosa and potential for inter-kingdom relationship. BMC Microbiol. 16:137. DOI:10.1186/s12866-016-0756-x

    View in Article CrossRef Google Scholar

    [134] Zheng W., Liu M., Lv X. et al. (2025). AhR governs lipid metabolism: The role of gut microbiota. Front. Microbiol. 16:1442282. DOI:10.3389/fmicb.2025.1442282

    View in Article CrossRef Google Scholar

    [135] Metidji A., Omenetti S., Crotta S. et al. (2018). The environmental sensor AHR protects from inflammatory damage by maintaining intestinal stem cell homeostasis and barrier integrity. Immunity 49:353−362.e5. DOI:10.1016/j.immuni.2018.07.010

    View in Article CrossRef Google Scholar

    [136] Zhang L., Ji Q., Chen Q. et al. (2023b). Akkermansia muciniphila inhibits tryptophan metabolism via the AhR/β-catenin signaling pathway to counter the progression of colorectal cancer. Int. J. Biol. Sci. 19:4393−4410. DOI:10.7150/ijbs.85712

    View in Article CrossRef Google Scholar

    [137] Lee R., Li J., Li J. et al. (2022). Synthetic essentiality of tryptophan 2,3-dioxygenase 2 in APC -mutated colorectal cancer. Cancer Discov. 12:1702−1717. DOI:10.1158/2159-8290.CD-21-0680

    View in Article CrossRef Google Scholar

    [138] Huang T., Song J., Gao J. et al. (2022). Adipocyte-derived kynurenine promotes obesity and insulin resistance by activating the AhR/STAT3/IL-6 signaling. Nat. Commun. 13:3489. DOI:10.1038/s41467-022-31126-5

    View in Article CrossRef Google Scholar

    [139] Du M.X., Wang W., Jiang M.Z. et al. (2026). Christensenella massiliensis reduces kynurenine levels and alleviates obesity and related metabolic disorders in model mice. Gut Microbes. 18:2701382. DOI:10.1080/19490976.2026.2701382

    View in Article CrossRef Google Scholar

    [140] Nakagawa S., Yamaguchi K., Takane K. et al. (2024). Wnt/β-catenin signaling regulates amino acid metabolism through the suppression of CEBPA and FOXA1 in liver cancer cells. Commun. Biol. 7:510. DOI:10.1038/s42003-024-06202-9

    View in Article CrossRef Google Scholar

    [141] Madsen M. S., Siersbæk R., Boergesen M. et al. (2014). Peroxisome proliferator-activated receptor γ and C/EBPα synergistically activate key metabolic adipocyte genes by assisted loading. Mol. Cell. Biol. 34:939−954. DOI:10.1128/MCB.01344-13

    View in Article CrossRef Google Scholar

    [142] Pedersen H. K., Gudmundsdottir V., Nielsen H. B. et al. (2016). Human gut microbes impact host serum metabolome and insulin sensitivity. Nature 535:376−381. DOI:10.1038/nature18646

    View in Article CrossRef Google Scholar

    [143] Poncet N., Halley P.A., Lipina C. et al. (2020). Wnt regulates amino acid transporter Slc7a5 and so constrains the integrated stress response in mouse embryos. EMBO Rep. 21:EMBR201948469. DOI:10.15252/embr.201948469

    View in Article CrossRef Google Scholar

    [144] Wang D.Z., Chen G.Y., Li Y.F. et al. (2020). Comprehensive analysis of long non-coding RNA and mRNA expression profile in rectal cancer. Chin. Med. J. 133:1312−1321. DOI:10.1097/CM9.0000000000000753

    View in Article CrossRef Google Scholar

    [145] Wolfson R.L., Chantranupong L., Saxton R.A. et al. (2016). Sestrin2 is a leucine sensor for the mTORC1 pathway. Science 351:43−48. DOI:10.1126/science.aab2674

    View in Article CrossRef Google Scholar

    [146] Nicklin P., Bergman P., Zhang B. et al. (2009). Bidirectional transport of amino acids regulates mTOR and autophagy. Cell 136:521−534. DOI:10.1016/j.cell.2008.11.044

    View in Article CrossRef Google Scholar

    [147] Ricoult S.J.H. and Manning B.D. (2013). The multifaceted role of mTORC1 in the control of lipid metabolism. EMBO Rep. 14:242−251. DOI:10.1038/embor.2013.5

    View in Article CrossRef Google Scholar

    [148] Du D., Liu C., Qin M. et al. (2022). Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma. Acta Pharm. Sin. B. 12:558−580. DOI:10.1016/j.apsb.2021.09.019

    View in Article CrossRef Google Scholar

    [149] Tran T.Q., Hanse E.A., Habowski A.N. et al. (2020). α-Ketoglutarate attenuates Wnt signaling and drives differentiation in colorectal cancer. Nat. Cancer. 1:345−358. DOI:10.1038/s43018-020-0035-5

    View in Article CrossRef Google Scholar

    [150] Yochum G. S., Sherrick C. M., MacPartlin M. et al. (2010). A β-catenin/TCF-coordinated chromatin loop at MYC integrates 5′ and 3′ Wnt-responsive enhancers. Proc. Natl. Acad. Sci. U.S.A. 107:145−150. DOI:10.1073/pnas.0912294107

    View in Article CrossRef Google Scholar

    [151] Felsher D. W., and Bishop J.M. (1999). Reversible tumorigenesis by MYC in hematopoietic lineages. Mol. Cell. 4:199−207. DOI:10.1016/S1097-2765(00)80367-6

    View in Article CrossRef Google Scholar

    [152] Venkateswaran N., Lafita-Navarro M.C., Hao Y.H. et al. (2019). MYC promotes tryptophan uptake and metabolism by the kynurenine pathway in colon cancer. Genes Dev. 33:1236−1251. DOI:10.1101/gad.327056.119

    View in Article CrossRef Google Scholar

    [153] Zhao X., Petrashen A.P., Sanders J.A. et al. (2019). SLC1A5 glutamine transporter is a target of MYC and mediates reduced mTORC1 signaling and increased fatty acid oxidation in long-lived Myc hypomorphic mice. Aging Cell. 18:e12947. DOI:10.1111/acel.12947

    View in Article CrossRef Google Scholar

    [154] Wong C.C., Xu J., Bian X. et al. (2020). In colorectal cancer cells with mutant KRAS, SLC25A22-mediated glutaminolysis reduces DNA demethylation to increase WNT signaling, stemness, and drug resistance. Gastroenterology 159:2163−2180.e6. DOI:10.1053/j.gastro.2020.08.016

    View in Article CrossRef Google Scholar

    [155] Koh A., De Vadder F., Kovatcheva-Datchary P. et al. (2016). From dietary fiber to host physiology: Short-chain fatty acids as key bacterial metabolites. Cell 165:1332−1345. DOI:10.1016/j.cell.2016.05.041

    View in Article CrossRef Google Scholar

    [156] Louis P. and Flint H.J. (2017). Formation of propionate and butyrate by the human colonic microbiota. Environ. Microbiol. 19:29−41. DOI:10.1111/1462-2920.13589

    View in Article CrossRef Google Scholar

    [157] Bordonaro M., Lazarova D. L., and Sartorelli A. C. (2002). Cell type- and promoter-dependent modulation of the Wnt signaling pathway by sodium butyrate. Int. J. Cancer. 97:42−51. DOI:10.1002/ijc.1577

    View in Article CrossRef Google Scholar

    [158] Lazarova D.L., Chiaro C., Wong T. et al. (2013). CBP activity mediates effects of the histone deacetylase inhibitor butyrate on WNT activity and apoptosis in colon cancer cells. J. Cancer. 4:481−490. DOI:10.7150/jca.6583

    View in Article CrossRef Google Scholar

    [159] Chen J., Zhao K.N. and Vitetta L. (2019). Effects of intestinal microbial–elaborated butyrate on oncogenic signaling pathways. Nutrients 11:1026. DOI:10.3390/nu11051026

    View in Article CrossRef Google Scholar

    [160] Garavaglia B., Vallino L., Ferraresi A. et al. (2022). Butyrate inhibits colorectal cancer cell proliferation through autophagy degradation of β-catenin regardless of APC and β-catenin mutational status. Biomedicines 10:1131. DOI:10.3390/biomedicines10051131

    View in Article CrossRef Google Scholar

    [161] Chen D., Jin D., Huang S. et al. (2020). Clostridium butyricum, a butyrate-producing probiotic, inhibits intestinal tumor development through modulating Wnt signaling and gut microbiota. Cancer Lett. 469:456−467. DOI:10.1016/j.canlet.2019.11.019

    View in Article CrossRef Google Scholar

    [162] Ni M., Wang Z., Li Z. et al. (2025). Dietary supplement of sodium butyrate improves the growth performance and intestinal health by targeting Wnt/β-catenin signaling pathway in rabbits. Anim. Res. One Health. 3:389−404. DOI:10.1002/aro2.71

    View in Article CrossRef Google Scholar

    [163] Tyagi A.M., Yu M., Darby T.M. et al. (2018). The microbial metabolite butyrate stimulates bone formation via T regulatory cell-mediated regulation of WNT10B expression. Immunity 49:1116−1131.e7. DOI:10.1016/j.immuni.2018.10.013

    View in Article CrossRef Google Scholar

    [164] Tolhurst G., Heffron H., Lam Y.S. et al. (2012). Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein–coupled receptor FFAR2. Diabetes. 61:364−371. DOI:10.2337/db11-1019

    View in Article CrossRef Google Scholar

    [165] Geng H., Zhou W., Zhu B. et al. (2024). Intestinal flora modulates blood glucose via regulating the secretion of GLP-1 induced by propionate in mouse models of gestational diabetes mellitus. Research Square. DOI:10.21203/rs.3.rs-5276950/v1

    View in Article Google Scholar

    [166] Chambers E.S., Viardot A., Psichas A. et al. (2015). Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut 64:1744−1754. DOI:10.1136/gutjnl-2014-307913

    View in Article CrossRef Google Scholar

    [167] den Besten G., Bleeker A., Gerding A. et al. (2015). Short-chain fatty acids protect against high-fat diet–induced obesity via a PPARγ-dependent switch from lipogenesis to fat oxidation. Diabetes 64:2398−2408. DOI:10.2337/db14-1213

    View in Article CrossRef Google Scholar

    [168] Kimura I., Ozawa K., Inoue D. et al. (2013). The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat. Commun. 4:1829. DOI:10.1038/ncomms2852

    View in Article CrossRef Google Scholar

    [169] Gao Z., Yin J., Zhang J. et al. (2009). Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58:1509−1517. DOI:10.2337/db08-1637

    View in Article CrossRef Google Scholar

    [170] Yang J., Li G., Wang S. et al. (2025). Butyrate prevents obesity accompanied by HDAC9-mediated browning of white adipose tissue. Biomedicines 13:260. DOI:10.3390/biomedicines13020260

    View in Article CrossRef Google Scholar

    [171] Yang L., Huang Y., Chen M. et al. (2026). Pasteurized Akkermansia muciniphila AKK PROBIO attenuates obesity through gut Microbiota-SCFA-GLP-1 axis and potential involvement of AMPK/PPAR-α pathway. Probiotics Antimicrob. Proteins. 18:4812−4829. DOI:10.1007/s12602-025-10805-x

    View in Article CrossRef Google Scholar

    [172] Yu H., Li R., Huang H. et al. (2018). Short-chain fatty acids enhance the lipid accumulation of 3T3-L1 cells by modulating the expression of enzymes of fatty acid metabolism. Lipids 53:77−84. DOI:10.1002/lipd.12005

    View in Article CrossRef Google Scholar

    [173] Jiao A., Yu B., He J. et al. (2020). Short chain fatty acids could prevent fat deposition in pigs via regulating related hormones and genes. Food Funct. 11:1845−1855. DOI:10.1039/C9FO02585E

    View in Article CrossRef Google Scholar

    [174] Sun Y., Zhang J., Hong J. et al. (2023). Human RSPO1 mutation represses beige adipocyte thermogenesis and contributes to diet-induced adiposity. Adv. Sci. 10:2207152. DOI:10.1002/advs.202207152

    View in Article CrossRef Google Scholar

    [175] Gong J., Shen Y., Zhang H. et al. (2022). Gut microbiota characteristics of people with obesity by Meta-analysis of existing datasets. Nutrients 14:2993. DOI:10.3390/nu14142993

    View in Article CrossRef Google Scholar

    [176] Rodrigues V.F., Elias-Oliveira J., Pereira Í.S. et al. (2022). Akkermansia muciniphila and gut immune system: A good friendship that attenuates inflammatory bowel disease, obesity, and diabetes. Front. Immunol. 13:934695. DOI:10.3389/fimmu.2022.934695

    View in Article CrossRef Google Scholar

    [177] Ma X., Li M., Zhang Y. et al. (2025). Akkermansia muciniphila identified as key strain to alleviate gut barrier injury through Wnt signaling pathway. eLife 12:RP92906. DOI:10.7554/eLife.92906.5

    View in Article CrossRef Google Scholar

    [178] Badralmaa Y. and Natarajan V. (2025). Aberrant Wnt/β-catenin signaling in the mesenchymal stem cells of LZTFL1-depleted mice leads to increased adipogenesis, with implications for obesity. J. Biol. Chem. 301:108057. DOI:10.1016/j.jbc.2024.108057

    View in Article CrossRef Google Scholar

    [179] Emont M.P., Jacobs C., Essene A.L. et al. (2022). A single-cell atlas of human and mouse white adipose tissue. Nature 603:926−933. DOI:10.1038/s41586-022-04518-2

    View in Article CrossRef Google Scholar

    [180] Massier L., Jalkanen J., Elmastas M. et al. (2023). An integrated single cell and spatial transcriptomic map of human white adipose tissue. Nat. Commun. 14:1438. DOI:10.1038/s41467-023-36983-2

    View in Article CrossRef Google Scholar

    [181] Shao M., Vishvanath L., Busbuso N.C. et al. (2018). De novo adipocyte differentiation from Pdgfrβ+ preadipocytes protects against pathologic visceral adipose expansion in obesity. Nat. Commun. 9:890. DOI:10.1038/s41467-018-03196-x

    View in Article CrossRef Google Scholar

    [182] Braud L., Bernabe M., Vernerey J. et al. (2025). TERT expression attenuates metabolic disorders in obese mice by promoting adipose stem and progenitor cell expansion and differentiation. Mol. Metab. 102:102262. DOI:10.1016/j.molmet.2025.102262

    View in Article CrossRef Google Scholar

    [183] Wang J., Liu R., Wang F. et al. (2013). Ablation of LGR4 promotes energy expenditure by driving white-to-brown fat switch. Nat. Cell Biol. 15:1455−1463. DOI:10.1038/ncb2867

    View in Article CrossRef Google Scholar

    [184] Zhang Z., Wang L., Qiao H. et al. (2025). Cryo-EM structure of the full-length LGR4-RSPOs complex and a targeting nanobody for anti-obesity therapy. Nat. Commun. 16:8406. DOI:10.1038/s41467-025-63410-5

    View in Article CrossRef Google Scholar

    [185] Dougherty M.W. and Jobin C. (2023). Intestinal bacteria and colorectal cancer: Etiology and treatment. Gut Microbes. 15:2185028. DOI:10.1080/19490976.2023.2185028

    View in Article CrossRef Google Scholar

    [186] Rubinstein M.R., Wang X., Liu W. et al. (2013). Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe. 14:195−206. DOI:10.1016/j.chom.2013.07.012

    View in Article CrossRef Google Scholar

    [187] Dadgar-Zankbar L., Shariati A., Bostanghadiri N. et al. (2023). Evaluation of enterotoxigenic bacteroides fragilis correlation with the expression of cellular signaling pathway genes in Iranian patients with colorectal cancer. Infect. Agents Cancer. 18:48. DOI:10.1186/s13027-023-00523-w

    View in Article CrossRef Google Scholar

    [188] Kang X., Ng S.K., Liu C. et al. (2023). Altered gut microbiota of obesity subjects promotes colorectal carcinogenesis in mice. eBioMedicine 93:104670. DOI:10.1016/j.ebiom.2023.104670

    View in Article CrossRef Google Scholar

    [189] Parida S., Wu S., Siddharth S. et al. (2021). A procarcinogenic colon microbe promotes breast tumorigenesis and metastatic progression and concomitantly activates notch and β-catenin axes. Cancer Discov. 11:1138−1157. DOI:10.1158/2159-8290.CD-20-0537

    View in Article CrossRef Google Scholar

    [190] Cui B., Luo H., He B. et al. (2025). Gut dysbiosis conveys psychological stress to activate LRP5/β-catenin pathway promoting cancer stemness. Signal Transduct. Target. Ther. 10:79. DOI:10.1038/s41392-025-02159-1

    View in Article CrossRef Google Scholar

    [191] Lv J., Jin S., Zhou Y. et al. (2025). Gut microbiota-derived metabolite phenylacetylglutamine inhibits the progression of prostate cancer by suppressing the Wnt/β-catenin signaling pathway. Front. Pharmacol. 16:1528058. DOI:10.3389/fphar.2025.1528058

    View in Article CrossRef Google Scholar

    [192] Agus A., Clément K. and Sokol H. (2021). Gut microbiota-derived metabolites as central regulators in metabolic disorders. Gut 70:1174−1182. DOI:10.1136/gutjnl-2020-323071

    View in Article CrossRef Google Scholar

    [193] Michael D. R., Jack A. A., Masetti G. et al. (2020). A randomised controlled study shows supplementation of overweight and obese adults with lactobacilli and bifidobacteria reduces bodyweight and improves well-being. Sci. Rep. 10:4183. DOI:10.1038/s41598-020-60991-7

    View in Article CrossRef Google Scholar

    [194] Depommier C., Everard A., Druart C. et al. (2019). Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat. Med. 25:1096−1103. DOI:10.1038/s41591-019-0495-2

    View in Article CrossRef Google Scholar

    [195] Chen Z., Guo L., Zhang Y. et al. (2014). Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesity. J. Clin. Invest. 124:3391−3406. DOI:10.1172/JCI72517

    View in Article CrossRef Google Scholar

    [196] Tian Q., Zhao J., Yang Q. et al. (2020). Dietary alpha-ketoglutarate promotes beige adipogenesis and prevents obesity in middle-aged mice. Aging Cell. 19:e13059. DOI:10.1111/acel.13059

    View in Article CrossRef Google Scholar

    [197] Kahn M. (2014). Can we safely target the WNT pathway. Nat. Rev. Drug Discov. 13:513−532. DOI:10.1038/nrd4233

    View in Article CrossRef Google Scholar

    [198] Rodon J., Argilés G., Connolly R.M. et al. (2021). Phase 1 study of single-agent WNT974, a first-in-class porcupine inhibitor, in patients with advanced solid tumours. Br. J. Cancer. 125:28−37. DOI:10.1038/s41416-021-01389-8

    View in Article CrossRef Google Scholar

    [199] Jackstadt R., Hodder M.C. and Sansom O.J. (2020). WNT and β-catenin in cancer: Genes and therapy. Annu. Rev. Cancer Biol. 4:177−196. DOI:10.1146/annurev-cancerbio-030419-033628

    View in Article CrossRef Google Scholar

    [200] Kuhnert F., Davis C.R., Wang H.T. et al. (2004). Essential requirement for Wnt signaling in proliferation of adult small intestine and colon revealed by adenoviral expression of Dickkopf-1. Proc. Natl. Acad. Sci. U.S.A. 101:266−271. DOI:10.1073/pnas.2536800100

    View in Article CrossRef Google Scholar

    [201] Baron R. and Kneissel M. (2013). WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat. Med. 19:179−192. DOI:10.1038/nm.3074

    View in Article CrossRef Google Scholar

    [202] Chen-Liaw A., Aggarwala V., Mogno I. et al. (2025). Gut microbiota strain richness is species specific and affects engraftment. Nature 637:422−429. DOI:10.1038/s41586-024-08242-x

    View in Article CrossRef Google Scholar

    [203] Fan Y., Ni M., Aggarwala V. et al. (2025). Long-read metagenomics for strain tracking after faecal microbiota transplant. Nat. Microbiol. 10:3258−3271. DOI:10.1038/s41564-025-02164-8

    View in Article CrossRef Google Scholar

    [204] Peery A. F., Kelly C. R., Kao D. et al. (2024). AGA clinical practice guideline on fecal microbiota-based therapies for select gastrointestinal diseases. Gastroenterology 166:409−434. DOI:10.1053/j.gastro.2024.01.008

    View in Article CrossRef Google Scholar

    [205] Tirosh A., Calay E. S., Tuncman G. et al. (2019). The short-chain fatty acid propionate increases glucagon and FABP4 production, impairing insulin action in mice and humans. Sci. Transl. Med. 11:eaav0120. DOI:10.1126/scitranslmed.aav0120

    View in Article CrossRef Google Scholar

  • Cite this article:

    He C., Liu C., Li Y., et al. (2026). Wnt signaling arranges the fate of lipid metabolism: The role of gut microbes. The Innovation Nutrition 1:100039. https://doi.org/10.59717/j.xinn-nutri.2026.100039
    He C., Liu C., Li Y., et al. (2026). Wnt signaling arranges the fate of lipid metabolism: The role of gut microbes. The Innovation Nutrition 1:100039. https://doi.org/10.59717/j.xinn-nutri.2026.100039

Welcome!

To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.

Figures(4)     Tables(3)

Share

  • Share the QR code with wechat scanning code to friends and circle of friends.

Article Metrics

Article views(731) PDF downloads(271)

Relative Articles

Cited by

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint